SG Americas Securities’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-12,140
Closed -$1.22M 3034
2015
Q1
$1.22M Buy
12,140
+8,681
+251% +$578K 0.01% 1042
2014
Q4
$182K Buy
+3,459
New +$102K ﹤0.01% 2492

SG Americas Securities's ASPX Position: Q2 2015 in Review

SG Americas Securities sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 12,140 shares — an estimated $1.22M sold.

SG Americas Securities first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $1.22M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • SG Americas Securities reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • SG Americas Securities sold 12,140 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.22M.
  • SG Americas Securities first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • SG Americas Securities's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.22M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on SG Americas Securities's 13F filing for Q2 2015, filed 6 Aug 2015.